Literature DB >> 15240345

Glycolate and glyoxylate metabolism in HepG2 cells.

Paul R S Baker1, Scott D Cramer, Martha Kennedy, Dean G Assimos, Ross P Holmes.   

Abstract

Oxalate synthesis in human hepatocytes is not well defined despite the clinical significance of its overproduction in diseases such as the primary hyperoxalurias. To further define these steps, the metabolism to oxalate of the oxalate precursors glycolate and glyoxylate and the possible pathways involved were examined in HepG2 cells. These cells were found to contain oxalate, glyoxylate, and glycolate as intracellular metabolites and to excrete oxalate and glycolate into the medium. Glycolate was taken up more effectively by cells than glyoxylate, but glyoxylate was more efficiently converted to oxalate. Oxalate was formed from exogenous glycolate only when cells were exposed to high concentrations. Peroxisomes in HepG2 cells, in contrast to those in human hepatocytes, were not involved in glycolate metabolism. Incubations with purified lactate dehydrogenase suggested that this enzyme was responsible for the metabolism of glycolate to oxalate in HepG2 cells. The formation of 14C-labeled glycine from 14C-labeled glycolate was observed only when cell membranes were permeabilized with Triton X-100. These results imply that peroxisome permeability to glycolate is restricted in these cells. Mitochondria, which produce glyoxylate from hydroxyproline metabolism, contained both alanine:glyoxylate aminotransferase (AGT)2 and glyoxylate reductase activities, which can convert glyoxylate to glycine and glycolate, respectively. Expression of AGT2 mRNA in HepG2 cells was confirmed by RT-PCR. These results indicate that HepG2 cells will be useful in clarifying the nonperoxisomal metabolism associated with oxalate synthesis in human hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240345     DOI: 10.1152/ajpcell.00238.2004

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  38 in total

1.  Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism.

Authors:  Ruth Belostotsky; James Jonathon Pitt; Yaacov Frishberg
Journal:  J Mol Med (Berl)       Date:  2012-06-24       Impact factor: 4.599

2.  An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.

Authors:  Abigail Liebow; Xingsheng Li; Timothy Racie; Julia Hettinger; Brian R Bettencourt; Nader Najafian; Patrick Haslett; Kevin Fitzgerald; Ross P Holmes; David Erbe; William Querbes; John Knight
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

3.  Metabolism of primed, constant infusions of [1,2-¹³C₂] glycine and [1-¹³C₁] phenylalanine to urinary oxalate.

Authors:  John Knight; Dean G Assimos; Michael F Callahan; Ross P Holmes
Journal:  Metabolism       Date:  2010-10-30       Impact factor: 8.694

4.  Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.

Authors:  Xingsheng Li; John Knight; Sonia Fargue; Brianna Buchalski; Zhengrong Guan; Edward W Inscho; Abigail Liebow; Kevin Fitzgerald; William Querbes; W Todd Lowther; Ross P Holmes
Journal:  Biochim Biophys Acta       Date:  2015-12-02

5.  A weak link in metabolism: the metabolic capacity for glycine biosynthesis does not satisfy the need for collagen synthesis.

Authors:  Enrique Meléndez-Hevia; Patricia De Paz-Lugo; Athel Cornish-Bowden; María Luz Cárdenas
Journal:  J Biosci       Date:  2009-12       Impact factor: 1.826

6.  Stiripentol protects against calcium oxalate nephrolithiasis and ethylene glycol poisoning.

Authors:  Marine Le Dudal; Léa Huguet; Joëlle Perez; Sophie Vandermeersch; Elise Bouderlique; Ellie Tang; Carole Martori; Nicole Chemaly; Rima Nabbout; Jean-Philippe Haymann; Vincent Frochot; Laurent Baud; Georges Deschênes; Michel Daudon; Emmanuel Letavernier
Journal:  J Clin Invest       Date:  2019-04-04       Impact factor: 14.808

7.  Dark Hydrazone Fluorescence Labeling Agents Enable Imaging of Cellular Aldehydic Load.

Authors:  Lik Hang Yuen; Nivedita S Saxena; Hyun Shin Park; Kenneth Weinberg; Eric T Kool
Journal:  ACS Chem Biol       Date:  2016-06-24       Impact factor: 5.100

Review 8.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

9.  Bacterial quorum sensing, cooperativity, and anticipation of stationary-phase stress.

Authors:  Eunhye Goo; Charlotte D Majerczyk; Jae Hyung An; Josephine R Chandler; Young-Su Seo; Hyeonheui Ham; Jae Yun Lim; Hongsup Kim; Bongsoo Lee; Moon Sun Jang; E Peter Greenberg; Ingyu Hwang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

10.  Glyoxalate reductase/hydroxypyruvate reductase interacts with the sodium-dependent vitamin C transporter-1 to regulate cellular vitamin C homeostasis.

Authors:  Veedamali S Subramanian; Svetlana M Nabokina; Joseph R Patton; Jonathan S Marchant; Hamid Moradi; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-04-18       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.